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Dynamic exercise evokes sustained cardiovascular responses, which are characterized by arterial
pressure and heart rate increases. Although it is well accepted that there is central nervous system
mediation of cardiovascular adjustments during exercise, information on the role of neural pathways and
signaling mechanisms is limited. It has been reported that glutamate, by acting on NMDA receptors,
evokes the release of nitric oxide through activation of neuronal nitric oxide synthase (nNOS) in the
brain. In the present study, we tested the hypothesis that NMDA receptors and nNOS are involved in
cardiovascular responses evoked by an acute bout of exercise on a rodent treadmill. Moreover, we
investigated possible central sites mediating control of responses to exercise through the NMDA
receptor–nitric oxide pathway. Intraperitoneal administration of the selective NMDA glutamate receptor
antagonist dizocilpine maleate (MK-801) reduced both the arterial pressure and heart rate increase
evoked by dynamic exercise. Intraperitoneal treatment with the preferential nNOS inhibitor
7-nitroindazole reduced exercise-evoked tachycardiac response without affecting the pressor response.
Moreover, treadmill running increased NO formation in the medial prefrontal cortex (MPFC), bed nucleus
of the stria teminalis (BNST) and periaqueductal gray (PAG), and this effect was inhibited by systemic
pretreatment with MK-801. Our ﬁndings demonstrate that NMDA receptors and nNOS mediate the
tachycardiac response to dynamic exercise, possibly through an NMDA receptor–NO signaling mechan-
ism. However, NMDA receptors, but not nNOS, mediate the exercise-evoked pressor response. The
present results also provide evidence that MPFC, BNST and PAG may modulate physiological adjustments
during dynamic exercise through NMDA receptor–NO signaling.
& 2013 Elsevier B.V. All rights reserved.1. Introduction
Nitric oxide (NO) is a small, relatively unstable molecule that
modulates many aspects of physiological functions (Bredt, 1999). It
is synthesized from L-arginine by three cell-speciﬁc nitric oxide
synthase (NOS) isoforms: neuronal nitric oxide synthase (nNOS)
and endothelial nitric oxide synthase (eNOS) are constitutively
expressed enzymes, whose activities are stimulated by increase in
intracellular Ca+2, whereas inducible nitric oxide synthase (iNOS)ll rights reserved.
:+55 16 3633 2301.
Department of Natural Active
l Sciences, São Paulo State
mpus Universitário),
el.: +55 16 3301 6982;
Resstel),
. Crestani).is calcium-independent and mediates immune functions for NO
(Alderton et al., 2001). The NO acts in the central nervous system
(CNS) as a signaling molecule and has been considered an atypical
neurotransmitter (Prast and Philippu, 2001; Garthwaite, 2008;
Zhou and Zhu, 2009). Garthwaite et al. (1988) demonstrated that
activation of NMDA receptors present in postsynaptic neurons in
the CNS results in the formation of NO, through a mechanism
dependent on Ca+2. Therefore, it has been proposed that the nNOS
enzyme in the brain is activated in response to Ca+2 inﬂux
following the activation of NMDA receptors by glutamate
(Garthwaite, 2008; Zhou and Zhu, 2009).
It has been demonstrated that dynamic exercise activates
numerous supra-medullary structures involved in control of
cardiovascular function, such as the medial prefrontal cortex
(MPFC), bed nucleus of the stria terminalis (BNST), paraventricular
nucleus of the hypothalamus (PVN) and periaqueductal gray (PAG)
(Timofeeva et al., 2003). Moreover, functional results have sup-
ported a role of these structures in cardiovascular adjustments to
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et al., 2011). NMDA glutamate receptor and nNOS interaction is an
important signaling mechanism involved in control of autonomic
and cardiovascular function in several CNS regions (Wu et al.,
2000; Li et al., 2001; Ryu et al., 2001; Resstel and Correa, 2006;
Karlsson et al., 2007; Tavares et al., 2007; Alves et al., 2009;
Busnardo et al., 2010). Furthermore, acute exercise by contractions
of the tibialis anterior muscle increased nitrite, a stable metabolite
of NO, in the brain (Paula et al., 2005). Although there are the
above cited results, the involvement of NMDA glutamate receptors
and nNOS mechanisms in cardiovascular adjustment during
dynamic exercise has never been investigated.
Therefore, in the present study we tested the hypothesis that
NMDA glutamate receptors and the nNOS enzyme are involved in
cardiovascular responses observed during dynamic exercise. To
test this hypothesis, we investigated the effect of treatment with a
selective NMDA glutamate receptor antagonist or a preferential
nNOS inhibitor on both pressor and tachycardiac responses elicited
by an acute bout of exercise on a rodent treadmill. Moreover, in
order to investigate possible central sites mediating control of
cardiovascular responses to dynamic exercise through NMDA
receptor–NO signaling mechanisms, we evaluated the effect of an
acute bout of exercise on NO formation in supra-medullary
structures involved in cardiovascular control. A possible involve-
ment of the activation of NMDA glutamate receptors in central NO
production was also studied.2. Materials and methods
2.1. Animals
Eighty-ﬁve male Wistar rats weighing 190–210 g at the begin-
ning of the experiments were used in the present experiments.
Animals were housed in plastic cages in a temperature-controlled
room (2471 1C) under standard laboratory conditions with free
access to food and water and a 12 h light/dark cycle (lights on at
06:00 am). Procedures were conducted in conformity with the
Brazilian Society of Neuroscience and Behavior guidelines for the
care and use of laboratory animals, which are in compliance with
international laws and politics. The Institution's Animal Ethics
Committee approved the housing conditions and experimental
procedures.
2.2. Surgical preparation
One day before the trial (De Angelis et al., 2006; Higa-Taniguchi
et al., 2009; Alves et al., 2011), rats were anesthetized with
tribromoethanol (250 mg/kg, i.p.) and a catheter was inserted into
the abdominal aorta through the femoral artery for cardiovascular
recording. Catheters consisted of a 4 cm piece of PE-10 heat-bound
to a 13 cm piece of PE-50 (Clay Adams, Parsippany, New Jersey,
USA) and were tunneled under the skin and exteriorized on the
animal's dorsum. After surgery, the animals received a poly-
antibiotic (Pentabioticos, Fort Dodge, Cotia, SP, Brazil), with
streptomycins and penicillins, to prevent infection and the non-
steroidal anti-inﬂammatory ﬂunixine meglumine (Banamines,
Schering Plough, Campinas, SP, Brazil) for post-operation
analgesia.
2.3. Measurement of cardiovascular responses
The arterial cannula was connected to a pressure transducer
(DPT100, Utah Medical Products Inc., Midvale, UT, USA) and the
pulsate arterial pressure was recorded using an ampliﬁer (Quad
Bridge Amp, ML224, ADInstruments, NSW, Australia) and anacquisition board (PowerLab 4/30, ML866/P, ADInstruments,
NSW, Australia) connected to a personal computer. Both mean
arterial pressure (MAP) and HR values were derived from pulsate
arterial pressure recordings.2.4. Measurement of nitrogen oxides (NOx)
Immediately after an acute bout of exercise on the rodent
treadmill (0.8 km/h for 6 min), rats were decapitated and the
brains immediately removed. The medial prefrontal cortex (MPFC),
bed nucleus of the stria terminalis (BNST), paraventricular nucleus
of the hypothalamus (PVN), dorsal and ventral hippocampus and
periaqueductal gray (PAG) were bilaterally dissected, homoge-
nized in ice-cold lysis buffer (Tris–HCl 20 mM pH 7.6, glycerol
10%, NaCl 137 mM) and stored at −80 1C. The nitrogen oxide (NOx)
assay was adapted from that described previously (Bories and
Bories, 1995). Brieﬂy, before the NOx assay, homogenates were
centrifuged at 20,000g for 10 min at 4 1C. After centrifugation, the
supernatant was removed and incubated overnight with 0.5 mg/
ml β-NADPH (Sigma-Aldrich, St. Louis, MO, USA) and 0.2 U/ml
nitrate reductase (Sigma-Aldrich) in KH2PO4 buffer (0.2 M, pH 7.6)
at 37 1C for reduction of nitrate to nitrite. Nitrite level was
determined by adding the Griess reagent (N-(1-naphthyl)ethyle-
nediamine dihydrochloride and sulfanilic acid) (Molecular Probes,
Eugene, OR, USA) to the samples, according to the manufacturer's
instructions. After 10 min of incubation at room temperature, the
absorbance at 540 nm was determined and nitrite concentrations
were calculated from the sodium nitrite (Sigma-Aldrich, St. Louis,
MO, USA) standard curve. The content of protein in individual
samples was measured using the Bradford reagent (Sigma-Aldrich,
St. Louis, MO, USA) using serum albumin as standard (Biorad,
Wien, Austria). All measurements were performed in triplicate and
results were expressed as μM NOx/μg protein.2.5. Drugs
Dizocilpine maleate (MK-801) (Sigma-Aldrich, St. Louis, MO,
USA), a selective and non-competitive NMDA receptor antagonist,
and the anesthetic tribromoethanol (Sigma-Aldrich) were
dissolved in saline (0.9% NaCl). The preferential nNOS inhibitor
7-nitroindazole (7-NI) (Sigma-Aldrich) was dissolved in dimethyl
sulfoxide (DMSO). Flunixine meglumine (Banamines, Schering
Plough, Campinas, SP, Brazil) and a poly-antibiotic preparation of
streptomycins and penicillins (Pentabioticos, Fort Dodge, Cotia, SP,
Brazil) were used as provided.2.6. Experimental protocols
Before surgical preparation all animals were familiarized with
exercise on the rodent treadmill (Insight, Ribeirão Preto, SP, Brazil)
for at least one week. During the familiarization period, animals
ran daily on the treadmill at a speed of 0.3–0.8 km/h and 0% grade
for 10 min. No electrical stimulation was used to induce them
to run.
On the trial day, animals were brought to the experimental
room in their home cages. Animals were allowed one hour to
adapt to the conditions of the experimental room, such as sound
and illumination, before starting experiments. The experimental
room had controlled temperature (24 1C) and was acoustically
isolated from the main laboratory.
Table 1
Basal values of mean arterial pressure (MAP) and heart rate (HR).
Group MAP (mmHg) HR (bpm)
Untreated n¼5 9672 366711
Saline n¼6 10173 371711
DMSO n¼5 10272 36877
F(2,15)¼1.5, P40.05 F(2,15)¼0.1, P40.05
Vehicle (saline) n¼6 10173 371711
MK-801 0.03 mg/kg n¼5 10273 36078
MK-801 0.1 mg/kg n¼5 9572 398714
MK-801 0.3 mg/kg n¼5 10672 408714
F(3,20)¼1.8, P40.05 F(3,20)¼2.8, P40.05
Vehicle (DMSO) n¼5 10272 36877
7-NI 15 mg/kg n¼5 10173 349712
7-NI 30 mg/kg n¼5 9972 36376
7-NI 45 mg/kg n¼5 9973 36379
F(3,19)¼0.3, P40.05 F(3,19)¼0.6, P40.05
The values are means7S.E.M., One-way ANOVA.
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antagonist MK-801 or the preferential nNOS inhibitor 7-NI on
cardiovascular changes induced by dynamic exercise
Rats received an intraperitoneal injection of the selective and
non-competitive NMDA receptor antagonist MK-801 (0.03, 0.1 or
0.3 mg/kg), the preferential nNOS inhibitor 7-nitroindazole (7-NI)
(15, 30 or 45 mg/kg) or the respective vehicles. The solutions were
administrated in a volume of 1 ml/kg. Thirty minutes after treat-
ment, the animals were submitted to an acute exercise test on the
rodent treadmill. The test consisted of exercise at 0.8 km/h for
6 min (Higa-Taniguchi et al., 2009; Alves et al., 2011), which
corresponds to about 70% of the rats' maximum running capacity
on the treadmill. Each animal received only one injection. An
untreated group, which did not receive any treatment, was also
included in the study.
2.6.2. Effect of dynamic exercise and/or treatment with the selective
NMDA receptor antagonist MK-801 on NOx levels in the central
nervous system
A different set of animals was used in this protocol. Animals
were divided into four groups: (1) vehicle rest (saline, n¼7); (2)
MK-801 rest (0.1 mg/kg, n¼7); (3) vehicle exercise (n¼7); and
MK-801 exercise (n¼7). The solutions were administrated intra-
peritoneally in a volume of 1 ml/kg. Dose of MK-801 was based on
the results obtained in experiment 1. Thirty minutes after treat-
ment, the animals in groups “vehicle exercise” and “MK-801
exercise” were submitted to an acute exercise test on the rodent
treadmill (0.8 km/h for 6 min). The animals in groups “vehicle rest”
and “MK-801 rest” were placed on the treadmill without being
submitted to exercise. Immediately after the acute bout of exercise,
rats were decapitated and the brains immediately removed and
dissected for NOx assay.
2.7. Data analysis
The results were expressed as mean7S.E.M. Basal values of
MAP and HR were compared using one-way ANOVA. Time-course
curves of MAP and HR changes were compared using two-way
ANOVA with treatment as independent factor and time as
repeated measurement. The effect of dynamic exercise on NOx
levels was evaluated using two-way ANOVA with treatment and
exercise as independent factors. When interactions between the
factors were observed, one-way ANOVA followed by Bonferroni's
post-hoc test was used to compare the effect of the treatments on
the exercise-evoked MAP, HR and NOx level changes. Moreover,
nonlinear regression analysis was performed to investigate the
dose–effect relationship of treatment with crescents doses of MK-
801 and 7-NI on cardiovascular responses to dynamic exercise.
Differences were considered signiﬁcant at Po0.05 level.3. Results
3.1. Effect of treatment with the selective NMDA receptor antagonist
MK-801 or the preferential nNOS inhibitor 7-NI on cardiovascular
changes induced by dynamic exercise
Vehicles—Systemic administration of either saline or DMSO did
not affect basal values of either MAP or HR, when compared with
the untreated group (Table 1). Exercise on the treadmill caused a
marked and sustained increase of both MAP (time factor:
F(18,247)¼45, Po0.0001) and HR (time factor: F(18,247)¼160,
Po0.0001). Changes in MAP (treatment factor: F(2,247)¼1,
P40.05) and HR (treatment factor: F(2,247)¼3, P40.05) induced
by exercise in animals that received saline or DMSO were not
signiﬁcantly different from those of the untreated group.MK-801—Systemic administration of different doses (0.03,
0.1 or 0.3 mg/kg) of the selective and non-competitive NMDA
receptor antagonist MK-801 did not affect either MAP or HR
baseline (Table 1). Exercise on the treadmill caused a signiﬁcant
increase in MAP (time factor: F(18,323)¼36, Po0.0001) and HR
(time factor: F(18,323)¼78, Po0.0001) (Fig. 1). Administration of
MK-801 (0.1 and 0.3 mg/kg) reduced both the MAP (treatment
factor: F(3,323)¼66, Po0.0001) and HR (treatment factor:
F(3,323)¼72, Po0.0001) increase induced by dynamic exercise
(Fig. 1). Moreover, there was a signiﬁcant interaction between
treatment and time for the MAP (F(54,323)¼3, Po0.0001) and HR
(F(54,323)¼3, Po0.0001) responses. Nonlinear regression analysis
revealed that MK-801 effects on exercise-evoked cardiovascular
responses were dose-dependent, showing a signiﬁcant association
between drug doses and MAP (df¼13, r2¼0.62, Po0.05) and HR
(df¼13, r2¼0.59, Po0.05) increase (Fig. 1). Representative experi-
mental recordings showing effects of MK-801 treatment on cardi-
ovascular responses induced by exercise on the rodent treadmill
are presented in Fig. 2.
7-Nitroindazole—Systemic administration of different doses
(15, 30 or 45 mg/kg) of the preferential nNOS inhibitor 7-NI did
not affect either MAP or HR baseline (Table 1). Exercise on the
treadmill caused a signiﬁcant increase in both MAP (time factor:
F(18,304)¼72, Po0.0001) and HR (time factor: F(18,304)¼69,
Po0.0001) (Fig. 3). Treatment with 7-NI (30 and 45 mg/kg)
reduced the exercise-evoked HR increase (treatment factor:
F(3,304)¼120, Po0.0001) without signiﬁcantly affecting the MAP
response (treatment factor: F(3,304)¼2, P40.05) (Fig. 3). Moreover,
there was a signiﬁcant interaction between treatment and time for
the HR response (HR: F(54,304)¼5, Po0.0001 and MAP: F(54,304)¼1,
P40.05). Nonlinear regression analysis conﬁrmed that 7-NI effects
on exercise-evoked tachycardiac responses were dose-dependent,
showing a signiﬁcant association between drug doses and HR
response (HR: df¼13, r2¼0.78, Po0.05; MAP: r2¼0, P40.05)
(Fig. 3). Representative experimental recordings showing the
effects of 7-NI treatment on cardiovascular responses induced by
exercise on the treadmill are presented in Fig. 4.
3.2. Effect of the dynamic exercise and/or treatment with the
selective NMDA receptor antagonist MK-801 on NOx levels in the
central nervous system
Medial prefrontal cortex—Dynamic exercise on the treadmill
caused a signiﬁcant increase in NOx levels in the MPFC (exercise
Fig. 1. (Left) Time-course of changes in mean arterial pressure (ΔMAP) and heart rate (ΔHR) during dynamic exercise on the treadmill (0.8 km/h for 6 min) in rats treated
intraperitoneally with vehicle (saline, 1 ml/kg, n¼6) or different doses (0.03, 0.1 and 0.3 mg/kg, n¼5/group) of the selective and non-competitive NMDA receptor antagonist
MK-801. The onset of exercise was at t¼0. Circles represent the mean and bars the S.E.M. nPo0.05 indicates a signiﬁcant difference over the whole exercise period compared
to vehicle treated animals; ANOVA followed by Bonferroni's post test. (Right)Mean arterial pressure (ΔMAP) and heart rate (ΔHR) changes during exercise in rats treated with
increasing doses of MK-801 (0.03, 0.1 and 0.3 mg/kg, n¼5/group). V: vehicle (saline, 1 ml/kg). Dose–effect curves were generated by nonlinear regression analysis. Data
shown represent the means7S.E.M. of the variation of MAP and HR during the 6 min of exercise.
Fig. 2. Recording from individual representative animals illustrating changes in pulsatile arterial pressure (PAP), mean arterial pressure (MAP) and heart rate (HR) observed
during dynamic exercise on the treadmill after intraperitoneal treatment with vehicle (saline, 1 ml/kg) or the selective and non-competitive NMDA receptor antagonist
MK-801 (0.1 mg/kg). Note the decrease in both MAP and HR response to exercise in the animal that received MK-801.
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indicate a signiﬁcant effect of systemic treatment with MK-801
(treatment factor: F(1,24)¼0.2, P40.05) (Fig. 5). Also, there was no
interaction between treatment and exercise factors (F(1,24)¼0.1,
P40.05).
Bed nucleus of the stria terminalis—Dynamic exercise on the
treadmill caused a signiﬁcant increase in NOx levels in the BNST
(exercise factor: F(1,24)¼8, Po0.01) (Fig. 5). Analysis did not show
a signiﬁcant effect of treatment (treatment factor: F(1,24)¼2,
P40.05), but indicated interaction between treatment and exer-
cise factors (F(1,24)¼6, Po0.03) (Fig. 5). Post-hoc analysis revealed
that treatment with MK-801 inhibited the exercise-evoked
increase in NOx levels in the BNST (Po0.05).
Paraventricular nucleus of the hypothalamus—Analysis did
not indicate a signiﬁcant effect of either dynamic exercise (exercisefactor: F(1,24)¼2, P40.05) or treatment with MK-801 (treatment
factor: F(1,24)¼1, P40.05) on NOx levels in the PVN (Fig. 5).
Dorsal and ventral hippocampus—Analysis did not indicate a
signiﬁcant effect of either dynamic exercise (exercise factor:
F(1,24)¼0.1, P40.05) or treatment with MK-801 (treatment factor:
F(1,24)¼0.6, P40.05) on NOx levels in the dorsal hippocampus
(DH) (Fig. 5). Analysis also did not indicate a signiﬁcant effect of
either dynamic exercise on the treadmill (exercise factor:
F(1,24)¼0.3, P40.05) or treatment with MK-801 (treatment factor:
F(1,24)¼3, P40.05) on NOx levels in the ventral hippocampus (VH)
(Fig. 5).
Periaqueductal gray—Dynamic exercise on the treadmill
caused a signiﬁcant increase in NOx levels in the periaqueductal
gray (PAG) (exercise factor: F(1,24)¼12, Po0.002) (Fig. 5). Analysis
also indicated a signiﬁcant effect of treatment with MK-801
Fig. 3. (Left) Time-course of changes in mean arterial pressure (ΔMAP) and heart rate (ΔHR) during dynamic exercise on the treadmill (0.8 km/h for 6 min) in rats treated
intraperitoneally with vehicle (DMSO, 1 ml/kg, n¼5) or different doses (15, 30 and 45 mg/kg, n¼5/group) of the preferential nNOS inhibitor 7-nitroindazole (7-NI). The onset
of exercise was at t¼0. Circles represent the mean and bars the S.E.M. nPo0.05 indicates a signiﬁcant difference over the whole exercise period compared to vehicle treated
animals; ANOVA followed by Bonferroni's post test. (Right) Mean arterial pressure (ΔMAP) and heart rate (ΔHR) changes during dynamic exercise in rats treated with
increasing doses of 7-NI (15, 30 and 45 mg/kg, n¼5/group). V: vehicle (saline, 1 ml/kg). Dose–effect curves were generated by nonlinear regression analysis. Data shown
represent the means7S.E.M. of the variation of MAP and HR during the 6 min of exercise.
Fig. 4. Recording from individual representative animals illustrating changes in pulsatile arterial pressure (PAP), mean arterial pressure (MAP) and heart rate (HR) observed
during dynamic exercise on the treadmill after intraperitoneal treatment with vehicle (DMSO, 1 ml/kg) or the preferential nNOS inhibitor 7-nitroindazole (7-NI) (30 mg/kg).
Note the decrease in the HR response to exercise in the animal that received 7-NI.
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treatment and exercise (F(1,24)¼12, Po0.003). Post-hoc analysis
revealed that treatment with MK-801 inhibited the exercise-
evoked increase of NOx levels in the PAG (Po0.001) (Fig. 5).4. Discussion
Our ﬁndings provide the ﬁrst direct evidence for the involve-
ment of NMDA glutamate receptors and nNOS in cardiovascular
adjustments during dynamic exercise. We observed that treatment
with the selective and non-competitive NMDA receptor antagonist
MK-801 reduced both the MAP and HR increase induced by
exercise in a dose-dependent manner. Treatment with thepreferential nNOS inhibitor 7-NI dose-dependently decreased HR
response to exercise without affecting pressor response. Moreover,
treadmill running increased NOx levels in supra-medullary struc-
tures involved in control of cardiovascular function (MPFC, BNST
and PAG), and this effect was inhibited after blockade of NMDA
glutamate receptors.
The nNOS isoform was ﬁrst found in neurons (Bredt et al.,
1990). However, further studies have also identiﬁed neuronal
synthesis of NO in skeletal, cardiac and smooth muscles, lung
epithelial cells and skin (Asano et al., 1994; Kobzik et al., 1994;
Schwarz et al., 1999; Xu et al., 1999; Guix et al., 2005). An
important role has been described for nNOS-derived NO in
regulation of kidneys, adrenal, coronary and liver blood ﬂow at
rest (Ichihara et al., 1998; Wakeﬁeld et al., 2003; Seddon et al.,
Fig. 5. Effect of dynamic exercise on the treadmill (0.8 km/h for 6 min) on NOx levels in the medial prefrontal cortex (MPFC), bed nucleus of the stria terminalis (BNST),
paraventricular nucleus of the hypothalamus (PVN), ventral (VH) and dorsal (DH) hippocampus and periaqueductal gray (PAG) in animals treated intraperitoneally with
vehicle (saline, 1 ml/kg) or the selective and non-competitive NMDA receptor antagonist MK-801 (0.1 mg/kg). Columns represent the mean and bars the S.E.M. nPo0.05
compared with the same treatment at rest, #Po0.05 compared with the vehicle group under the same conditions; ANOVA followed by Bonferroni's post test.
L.H.A Camargo et al. / European Journal of Pharmacology 713 (2013) 16–24 212009; Copp et al., 2010). Moreover, nNOS seems to be an
important regulator of visceral and muscle blood ﬂow during
exercise (Lai et al., 2009; Copp et al., 2010). Redistribution of blood
ﬂow is an important mechanism involved in the arterial pressure
response to exercise (Waldrop et al., 1996). However, blockade of
nNOS by systemic treatment with 7-NI reduced the HR increase
from exercise without affecting the pressor response. The increase
of HR during exercise is mediated by neural mechanisms (i.e.,
changes in autonomic activity) (Goldsmith et al., 2000). Therefore,
our ﬁndings suggest that changes in cardiac response to exercise
reported in the present study are mainly due to a central blockade
of nNOS in the brain. Moreover, our results are similar to those
demonstrating that a reduction in HR responses does not affect the
exercise-induced arterial pressure increase (Overton, 1993).
A recent study in rats showed that systemic treatment with the
selective nNOS inhibitor S-metil-L-tiocitruline (SMLT) did not
affect either arterial pressure, HR or hyperemic responses to
dynamic exercise on a treadmill (Copp et al., 2010). The reasons
for the discrepancy with our ﬁndings are not clear. In vitro studies
have demonstrated that the selectivity of SMLT for nNOS is higher
than that of 7-NI (Furﬁne et al., 1994; Alderton et al., 2001).However, it has been proposed that the selectivity of NOS
inhibitors in vivo may be inﬂuenced by other factors, such as a
cell-type speciﬁcity effect (e.g., neuronal vs vascular) and metabo-
lism (Alderton et al., 2001). Several studies have demonstrated
that systemic administration of 7-NI inhibits nNOS activity in the
CNS (Babbedge et al., 1993; MacKenzie et al., 1994; Ryu et al.,
2001; Zhou et al., 2007). A preferential blockade of nNOS in the
CNS has been further evidenced by the failure of 7-NI to increase
arterial pressure (Babbedge et al., 1993; Moore et al., 1993), an
effect thought to be mediated by inhibition of the vascular action
of NO (Alderton et al., 2001). Moreover, 7-NI does not affect skin
blood ﬂow in rats (Kajekar et al., 1995). Most previous studies
investigating the role of nNOS-derived NO in blood ﬂow regulation
have used SMLT (Ichihara et al., 1998; Wakeﬁeld et al., 2003;
Seddon et al., 2008, 2009; Copp et al., 2010). Contrary to 7-NI,
systemic administration of SMLT increases baseline arterial pres-
sure (Wakeﬁeld et al., 2003; Patterson et al., 2008; Copp et al.,
2010). These results suggest a reduced inﬂuence of 7-NI in the
vascular action of NO, when compared to SMLT. Therefore,
differences in nNOS inhibitor may explain the differences between
our ﬁndings and those of Copp et al. (2010). Moreover, the above
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tachycardiac response following 7-NI administration are possibly
mediated by blockade of nNOS in the brain.
The nNOS enzyme in the CNS is activated in response to Ca+2
inﬂux following activation of NMDA receptors (Garthwaite, 2008;
Zhou and Zhu, 2009). Despite reports of the expression of other
NOS isoforms in the brain (Dinerman et al., 1994; Amitai, 2010),
nNOS seems to be the major isoform involved in NO synthesis in
the CNS (Garthwaite, 2008; Zhou and Zhu, 2009). Indeed, nitric
oxide synthase catalytic activity in the brain of animals deﬁcient
for nNOS (nNOS−/−) was reduced by more than 90% (Huang et al.,
1993). Therefore, since both MK-801 and 7-NI reduced the tachy-
cardiac response observed during exercise, our results suggest that
the cardiac response during dynamic exercise is possibly mediated
by a NMDA receptor–NO signaling mechanism. However, arterial
pressure response to exercise seems to be mediated by NMDA
receptors through a mechanism independent of nNOS activation.
NO is an unstable gas that undergoes various reactions in
biological ﬂuids resulting in its rapid degradation (Guix et al.,
2005). Therefore, measurement of stable metabolites of NO, such
as nitrite and nitrate, has been used to evaluate NOS catalytic
activity and NO formation (Marzinzig et al., 1997). We observed in
the present study that treadmill running increased NOx levels in
the MPFC, BNST and PAG. Unexpectedly, treadmill running did not
signiﬁcantly increase NOx in the PVN. Previous results have
supported a role for the PVN in cardiovascular adjustments
associated with exercise (Jackson et al., 2005; de Abreu et al.,
2009; Stern et al., 2012). Moreover, some pieces of evidence have
suggested that nitrergic mechanisms within the PVN are asso-
ciated with cardiovascular adaptations to exercise training. For
example, nonselective inhibition of NO synthesis within the PVN
partly reverted adaptation in HR variability (increase in high-
frequency oscillations and decrease in low-frequency oscillations)
induced by exercise training (Mastelari et al., 2011). Moreover,
exercise training restored the altered control of autonomic and
cardiovascular functions by nitrergic mechanisms within the PVN
in heart failure rats (Zheng et al., 2005). Therefore, we cannot
exclude the possibility that PVN control of responses to dynamic
exercise is mediated by local formation of NO. The reasons for the
absence of a NOx increase in the PVN are not clear. A possible
explanation could be differences in NO inactivation in different
brain regions. Indeed, the brain has a very active mechanism of NO
inactivation (Hall and Garthwaite, 2006), but it has been proposed
that its activity may vary between brain regions (Garthwaite,
2008). Moreover, we cannot exclude the possibility that exercise
intensity or duration was insufﬁcient.
Interestingly, pretreatment with MK-801 inhibited exercise-
evoked increase in NOx levels in the BNST and PAG, thus suggest-
ing an important role of NMDA receptor activation in exercise-
evoked formation of NO in these structures. However, the increase
in NOx level in the MPFC was not affected by systemic treatment
with MK-801. Three mechanisms may explain the ﬁndings in the
MPFC. Firstly, nNOS activation in the MPFC could be mediated by a
mechanism independent of NMDA receptor activation. In addition
to regulation by the Ca+2/calmodullin complex, the main known
mechanism in which Ca+2 inﬂux following activation of NMDA
receptors activates nNOS, some studies have demonstrated that
nNOS possesses sites for phosphorylation and its activity may be
modulated by the action of protein kinases (Garthwaite, 2008).
Indeed, although controversial (Bredt et al., 1992), a moderate
increase in enzyme activity was identiﬁed after phosphorylation
by protein kinase C (Nakane et al., 1991). Furthermore, recent
studies have demonstrated that nNOS can bind to serotonin
transporters in the plasma membrane, which in turn increase
the nNOS enzymatic activity through a mechanism independent of
Ca+2 inﬂux (Chanrion et al., 2007; Garthwaite, 2007). A secondpossibility is that a mechanism other than nNOS activation may be
involved in exercise-induced NO formation in the MPFC. Although
nNOS is the most expressed NOS isoform in the brain (Garthwaite,
2008), there are reports that neurons in the CNS also contain eNOS
and iNOS (Dinerman et al., 1994; Amitai, 2010). Finally, we cannot
exclude the possibility that access of MK-801 may differ between
different sites in the CNS, and consequently the dose of the
antagonist was ineffective in blocking the NMDA receptor in the
MPFC. Therefore, further studies are necessary to clarify the
mechanisms involved in NO formation in the MPFC during
dynamic exercise. However, considered overall, the present results
provide initial evidence that the MPFC, BNST and PAG may
modulate responses to exercise through NMDA receptor and NO
signaling mechanisms. However, since the NMDA receptor–NO
pathway is an important signaling mechanism in other medullary
and supra-medullary structures involved in cardiovascular control
(Martins-Pinge et al., 2007; Lin, 2009), effects observed after
systemic pharmacological treatment may also be mediated by
action on other sites. Therefore, further studies are necessary to
clarify CNS sites controlling cardiovascular responses to dynamic
exercise through NMDA receptor and NO signaling.
Both the sympathetic and the parasympathetic branches of the
autonomic nervous system are involved in the control of cardio-
vascular activity during exercise. Blockade of cardiac parasympa-
thetic activity reveals that most of the initial cardiac response to
exercise is attributable to the withdrawal of tonic vagal activity,
whereas β-adrenergic blockade reveals the importance of
augmented cardiac sympathetic activity during exercise
(Overton, 1993; Goldsmith et al., 2000). Moreover, sympathetic-
mediated vasoconstriction diverts blood away from the kidneys
and splanchnic beds to active muscles, and is an important
mechanism involved in arterial pressure increase during exercise
(O'Hagan et al., 1993; Waldrop et al., 1996). Interaction between
NMDA receptors and nNOS is involved in tonic control of sympa-
thetic and parasympathetic activity in medullary and supra-
medullary structures (Martins-Pinge et al., 2007; Lin, 2009;
Busnardo et al., 2010). Therefore, it is possible that NMDA
receptors and nNOS could modulate the cardiac response during
exercise by inhibiting vagal neurons and/or by stimulating sympa-
thetic neurons. Also, facilitation of sympathetic neurons control-
ling vascular activity may mediate NMDA receptor control of
arterial pressure responses during exercise.
In summary, our results suggest that NMDA receptors and
nNOS mediate the tachycardiac response to dynamic exercise,
possibly through a NMDA receptor–NO signaling mechanism. On
the other hand, NMDA receptors, but not nNOS, mediate the
exercise-evoked pressor response. Present results also provide
initial evidence that MPFC, BNST and PAG may modulate responses
to exercise through NMDA receptor–NO signaling.Acknowledgments
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